Morgan Stanley
-
-
-
-
-
-
-
UPDATE: Morgan Stanley Starts Freeline Therapeutics (NASDAQ: FRLN) at Overweight
-
-
-
-
-
-
-
Notable Analyst Rating Changes 3/12: (AMRN) (WIN) (VRSK) Upgraded; (ALKS) (CNX) (MSI) Downgraded
-
-
-
-
-
-
-
Notable Analyst Rating Changes 03/02: (LOW) (LLY) (MSI) Upgraded; (TRV) (ALU) (AONE) Downgraded
-
-
-
-
-
-
-
Analyst Round-Up: New Coverage on Motorola Mobility (MMI), Motorola Solutions (MSI)
158,310 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All